Next Generation Antidepressants: Moving Beyond Monoamines to Discover Novel Treatment Strategies for Mood Disorders (Cambridge Medicine (Hardcover))

ISBN 10: 0521760585 ISBN 13: 9780521760584
Published by Cambridge University Press, 2010
Used hardcover

From HPB-Red, Dallas, TX, U.S.A. Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

AbeBooks Seller since 11 March 2019

This specific item is no longer available.

About this Item

Description:

Connecting readers with great books since 1972! Used textbooks may not include companion materials such as access codes, etc. May have some wear or writing/highlighting. We ship orders daily and Customer Service is our top priority! Seller Inventory # S_383300627

Report this item

Synopsis:

The future of mood-disorder research: covering identification of new therapeutic targets, preclinical models, and medicinal chemistry opportunities.

About the Authors: Chad E. Beyer is Prinicpal Research Scientist II at Pfizer Global Research and Development, Princeton, New Jersey and Adjunct Professor at Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

Stephen M. Stahl is Adjunct Professor of Psychiatry at the University of California San Diego, San Diego, California, and Neuroscience Education Institute, Carlsbad, California, USA.

"About this title" may belong to another edition of this title.

Bibliographic Details

Title: Next Generation Antidepressants: Moving ...
Publisher: Cambridge University Press
Publication Date: 2010
Binding: hardcover
Condition: Good

Top Search Results from the AbeBooks Marketplace

Stock Image

Published by Cambridge University Press, 2010
ISBN 10: 0521760585 ISBN 13: 9780521760584
Used Hardcover

Seller: WorldofBooks, Goring-By-Sea, WS, United Kingdom

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Hardback. Condition: Very Good. The book has been read, but is in excellent condition. Pages are intact and not marred by notes or highlighting. The spine remains undamaged. Seller Inventory # GOR014529170

Contact seller

Buy Used

£ 7.96
£ 5.60 shipping
Ships from United Kingdom to U.S.A.

Quantity: 1 available

Add to basket

Stock Image

Beyer, Chad E.
Published by Cambridge University Press, 2010
ISBN 10: 0521760585 ISBN 13: 9780521760584
Used Hardcover First Edition

Seller: Antiquariaat Die Sammlung, Amsterdam Zuidoost, Netherlands

Seller rating 3 out of 5 stars 3-star rating, Learn more about seller ratings

Hardcover. Condition: Fine. 1st Edition. 137 p. Seller Inventory # BK 1-3 450

Contact seller

Buy Used

£ 8.53
£ 17.25 shipping
Ships from Netherlands to U.S.A.

Quantity: 1 available

Add to basket

Stock Image

Published by Cambridge University Press, 2010
ISBN 10: 0521760585 ISBN 13: 9780521760584
Used Hardcover First Edition

Seller: Better World Books, Mishawaka, IN, U.S.A.

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Condition: Very Good. 1st Edition. Pages intact with possible writing/highlighting. Binding strong with minor wear. Dust jackets/supplements may not be included. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good. Seller Inventory # 56641004-6

Contact seller

Buy Used

£ 16.74
Free Shipping
Ships within U.S.A.

Quantity: 1 available

Add to basket

Stock Image

Published by Cambridge University Press, 2010
ISBN 10: 0521760585 ISBN 13: 9780521760584
New Hardcover

Seller: Ria Christie Collections, Uxbridge, United Kingdom

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Condition: New. In. Seller Inventory # ria9780521760584_new

Contact seller

Buy New

£ 137.85
£ 11.98 shipping
Ships from United Kingdom to U.S.A.

Quantity: Over 20 available

Add to basket

Stock Image

Edited by Chad E. Beyer , Stephen M. Stahl
Published by Cambridge University Press, 2010
ISBN 10: 0521760585 ISBN 13: 9780521760584
New Hardcover
Print on Demand

Seller: Revaluation Books, Exeter, United Kingdom

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Hardcover. Condition: Brand New. 1st edition. 150 pages. 9.49x6.30x0.59 inches. In Stock. This item is printed on demand. Seller Inventory # __0521760585

Contact seller

Buy New

£ 140.48
£ 10 shipping
Ships from United Kingdom to U.S.A.

Quantity: 1 available

Add to basket

Stock Image

Chad E. Beyer
Published by Cambridge University Press, 2010
ISBN 10: 0521760585 ISBN 13: 9780521760584
New Hardcover
Print on Demand

Seller: THE SAINT BOOKSTORE, Southport, United Kingdom

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Hardback. Condition: New. This item is printed on demand. New copy - Usually dispatched within 5-9 working days. Seller Inventory # C9780521760584

Contact seller

Buy New

£ 146.89
£ 15.55 shipping
Ships from United Kingdom to U.S.A.

Quantity: Over 20 available

Add to basket

Stock Image

Chad E. Beyer
ISBN 10: 0521760585 ISBN 13: 9780521760584
New Hardcover
Print on Demand

Seller: CitiRetail, Stevenage, United Kingdom

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Hardcover. Condition: new. Hardcover. The World Health Organization defines depression as a primary contributor to the global burden of disease and predicts it will become the second leading cause of death by 2020. The need to develop effective therapies has never been so pressing. Current antidepressant drugs have several limitations. This 2010 book looks at the future of mood-disorder research, covering the identification of new therapeutic targets, establishing new preclinical models, new medicinal chemistry opportunities, and fostering greater understanding of genetic influences. These strategies are likely to help build a better picture of the disease process, and lead to new opportunities for patient stratification and treatment. The ultimate goal for this strand of research is to develop more personalized and effective treatments for this chronic and debilitating condition. This is essential reading for all those involved in psychopharmacologic drug development, and mental health clinicians seeking a preview of discoveries soon to influence their practice. This 2010 book looks at the future of mood-disorder research, covering identification of new therapeutic targets, preclinical models, and medicinal chemistry opportunities, and increasing understanding of genetic influences. Essential reading for everyone involved in psychopharmacology development, and mental health clinicians seeking a preview of discoveries soon to influence their practice. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. Seller Inventory # 9780521760584

Contact seller

Buy New

£ 154.99
£ 37 shipping
Ships from United Kingdom to U.S.A.

Quantity: 1 available

Add to basket

Stock Image

Chad E. Beyer
ISBN 10: 0521760585 ISBN 13: 9780521760584
New Hardcover
Print on Demand

Seller: Grand Eagle Retail, Bensenville, IL, U.S.A.

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Hardcover. Condition: new. Hardcover. The World Health Organization defines depression as a primary contributor to the global burden of disease and predicts it will become the second leading cause of death by 2020. The need to develop effective therapies has never been so pressing. Current antidepressant drugs have several limitations. This 2010 book looks at the future of mood-disorder research, covering the identification of new therapeutic targets, establishing new preclinical models, new medicinal chemistry opportunities, and fostering greater understanding of genetic influences. These strategies are likely to help build a better picture of the disease process, and lead to new opportunities for patient stratification and treatment. The ultimate goal for this strand of research is to develop more personalized and effective treatments for this chronic and debilitating condition. This is essential reading for all those involved in psychopharmacologic drug development, and mental health clinicians seeking a preview of discoveries soon to influence their practice. This 2010 book looks at the future of mood-disorder research, covering identification of new therapeutic targets, preclinical models, and medicinal chemistry opportunities, and increasing understanding of genetic influences. Essential reading for everyone involved in psychopharmacology development, and mental health clinicians seeking a preview of discoveries soon to influence their practice. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. Seller Inventory # 9780521760584

Contact seller

Buy New

£ 156.28
Free Shipping
Ships within U.S.A.

Quantity: 1 available

Add to basket

Stock Image

Published by Cambridge University Press, 2010
ISBN 10: 0521760585 ISBN 13: 9780521760584
New Hardcover

Seller: California Books, Miami, FL, U.S.A.

Seller rating 4 out of 5 stars 4-star rating, Learn more about seller ratings

Condition: New. Seller Inventory # I-9780521760584

Contact seller

Buy New

£ 156.29
Free Shipping
Ships within U.S.A.

Quantity: Over 20 available

Add to basket

Seller Image

Beyer, Chad E.
Published by Cambridge University Press, 2011
ISBN 10: 0521760585 ISBN 13: 9780521760584
New Hardcover
Print on Demand

Seller: moluna, Greven, Germany

Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

Gebunden. Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. This 2010 book looks at the future of mood-disorder research, covering identification of new therapeutic targets, preclinical models, and medicinal chemistry opportunities, and increasing understanding of genetic influences. Essential reading for everyone i. Seller Inventory # 446946113

Contact seller

Buy New

£ 158.41
£ 42.26 shipping
Ships from Germany to U.S.A.

Quantity: Over 20 available

Add to basket

There are 11 more copies of this book

View all search results for this book